Roivant Sciences

www.roivant.com
151 W 42nd Street, 15th Floor
New York, NY 10036

Company Info

Phone
(212) 847-6204

Year Established
2014

Ticker
ROIV

Exchange
NASDAQ

Contacts

Matthew Gline
CEO

Amy Mahery
CCO

Srini Ramanathan, PhD
CDO

Richard Pulik
CFO

Jo Chen
General Counsel

Eric Venker
President & COO

Company Description

Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants -nimble and focused biopharmaceutical and health technology companies.